Williamstown, MA -- (SBWIRE) -- 11/15/2011 -- GlobalData's clinical trial report, "Choroidal Neovascularization Global Clinical Trials Review, H2, 2011" provides data on the Choroidal Neovascularization clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Choroidal Neovascularization. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Choroidal Neovascularization. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Full Report Details at
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Partial Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Choroidal Neovascularization
Subjects Recruited Over a Period of Time
Top Companies Participating in Choroidal Neovascularization Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Clinical Trial Overview of Novartis AG
Clinical Trial Overview of Allergan, Inc.
Notal Vision Ltd.
Clinical Trial Overview of Notal Vision Ltd.
Clinical Trial Overview of Santen Incorporated
Clinical Trial Overview of Pfizer Inc.
Clinical Trial Overview of OXiGENE, Inc.
Tennessee Retina, PC
Clinical Trial Overview of Tennessee Retina, PC
Chengdu Kanghong Pharmaceutical Group
Clinical Trial Overview of Chengdu Kanghong Pharmaceutical Group
Mid-Atlantic Retina Consultations, Inc
Clinical Trial Overview of Mid-Atlantic Retina Consultations, Inc
Steba Laboratories Ltd.
Clinical Trial Overview of Steba Laboratories Ltd.
Clinical Trial Overview of TargeGen, Inc.
Alexion Pharmaceuticals, Inc.
Clinical Trial Overview of Alexion Pharmaceuticals, Inc.
Clinical Trial Overview of Ophthotech Corp.
Clinical Trial Overview of Lpath, Inc.
Optical Imaging Ltd.
Clinical Trial Overview of Optical Imaging Ltd.
Light Sciences Oncology, Inc.
Clinical Trial Overview of Light Sciences Oncology, Inc.
Clinical Trial Overview of Genentech, Inc.
Eyetech Pharmaceuticals, Inc.
Clinical Trial Overview of Eyetech Pharmaceuticals, Inc.
Clinical Trial Overview of QLT Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Asociacion para Evitar la Ceguera en Mexico I.A.P.
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P.
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
Instituto de Olhos de Goiania
Clinical Trial Overview of Instituto de Olhos de Goiania
Oklahoma State University Center for Health Sciences
Clinical Trial Overview of Oklahoma State University Center for Health Sciences
Barnes Retina Institute
Clinical Trial Overview of Barnes Retina Institute
University of Illinois
Clinical Trial Overview of University of Illinois
Second University of Naples
Clinical Trial Overview of Second University of Naples
Ophthalmic Consultants of Boston
Clinical Trial Overview of Ophthalmic Consultants of Boston
Hokkaido University School of Medicine
Clinical Trial Overview of Hokkaido University School of Medicine
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Clinical Trial Overview of The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
St. Erik Eye Hospital
Clinical Trial Overview of St. Erik Eye Hospital
L.V. Prasad Eye Institute
Clinical Trial Overview of L.V. Prasad Eye Institute
Shaheed Beheshti Medical University
Clinical Trial Overview of Shaheed Beheshti Medical University
Retinal Consultants Medical Group
Clinical Trial Overview of Retinal Consultants Medical Group
Rafik Hariri University Hospital
Full Table of Contents is available at:
View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.